Replies to post #87031 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

No, it was not mentioned.

[DewDiligence]

Apparently, that trial not the new IST ADXS has been talking about. Rather, according to yesterday’s webcast, the new IST is slated to start in early 2019 and will test AXAL in combination with an unspecified “novel” drug in H&N cancer.